3590
K. Yamamoto et al.
PAPER
13C NMR (CDCl3): d = 19.44, 72.74, 115.05, 115.37, 125.98,
126.12, 127.59, 128.64, 128.77, 130.54, 135.14, 138.39, 138.44,
141.10, 160.16, 163.78.
MS (EI): m/z = 216 (M+), 199, 137.
HRMS: m/z (M+) calcd for C14H13FO: 216.0951; found: 216.0951.
Acknowledgement
We thank the Ministry of Education, Culture, Sports, Science and
Technology, Japan for support. K.K. was financially supported by
the Takeda Science Foundation.
References
(R)-(4-Methoxyphenyl)(2-tolyl)methanol [(R)-2s]
The assignment of the absolute configuration was determined by
comparison with the CD spectrum of known (R)-phenyl(2-
tolyl)methanol.12
(1) For a recent review, see: Schmidt, F.; Stemmler, R. T.;
Rudolph, J.; Bolm, C. Chem. Soc. Rev. 2006, 35, 454.
(2) Sakai, M.; Ueda, M.; Miyaura, N. Angew. Chem. Int. Ed.
1998, 37, 3279.
[a]D26 –10 (c 0.94, THF).
(3) Other asymmetric Rh-catalyzed arylations of aromatic
aldehydes with arylboronic acids: (a) Moreau, C.; Hague,
C.; Weller, A. S.; Frost, C. G. Tetrahedron Lett. 2001, 42,
6957. (b) Focken, T.; Rudolph, J.; Bolm, C. Synthesis 2005,
429. (c) Suzuki, K.; Ishii, S.; Kondo, K.; Aoyama, T. Synlett
2006, 648. (d) Suzuki, K.; Kondo, K.; Aoyama, T. Synthesis
2006, 1360. (e) Arao, T.; Sato, K.; Kondo, K.; Aoyama, T.
Chem. Pharm. Bull. 2006, 54, 1576. (f) Arao, T.; Suzuki,
K.; Kondo, K.; Aoyama, T. Synthesis 2006, 3809. (g) For a
Rh-catalyzed asymmetric arylation of a ketone group in
isatins, see: Shintani, R.; Inoue, M.; Hayashi, T. Angew.
Chem. Int. Ed. 2006, 45, 3353.
(4) (a) Yamamoto, T.; Ohta, T.; Ito, Y. Org. Lett. 2005, 7, 4153.
(b) Suzuki, K.; Arao, T.; Ishii, S.; Maeda, Y.; Kondo, K.;
Aoyama, T. Tetrahedron Lett. 2006, 47, 5789. (c) He, P.;
Lu, Y.; Dong, C.-G.; Hu, Q.-S. Org. Lett. 2007, 9, 343.
(d) Novodomska, A.; Dudicova, M.; Leroux, F. R.; Colobert,
F. Tetrahedron: Asymmetry 2007, 18, 1628. (e) Shirai, R.;
Shimazawa, R.; Kuriyama, M. J. Org. Chem. 2008, 73,
1597.
IR (neat): 3380 cm–1.
1H NMR (CDCl3): d = 2.08 (br s, 1 H), 2.20 (s, 3 H), 3.78 (s, 3 H),
5.94 (br s, 1 H), 6.84 (d, J = 8.5 Hz, 2 H), 7.08–7.32 (m, 5 H), 7.56
(d, J = 7.3 Hz, 1 H).
13C NMR (CDCl3): d = 19.42, 55.29, 72.96, 113.78, 125.79, 125.96,
127.27, 128.37, 130.37, 134.97, 135.05, 141.48, 158.89.
MS (EI): m/z = 228 (M+, bp), 211, 119.
HRMS: m/z (M+) calcd for C15H16O2: 228.1150; found: 228.1150.
(+)-(2-Ethoxyphenyl)phenylmethanol [(+)-2t]
[a]D22 +53 (c 1.17, THF).
The physical data were comparable to those reported.14
(R)-Orphenadrine (9)
To a stirred soln of (R)-phenyl(2-tolyl)methanol [(R)-2e, 201 mg,
1.01 mmol, 81% ee] and 2-chloro-N,N-dimethylacetamide (247 mg,
2.03 mmol) in DMF (5.0 mL) was added NaH (143 mg, 5.97 mmol,
60% in mineral oil) at 0 °C. The mixture was stirred at r.t. for 30
min, quenched with H2O, and extracted with EtOAc. The combined
extracts were washed with brine, dried (Na2SO4), and concentrated.
The residue was purified by column chromatography (silica gel,
EtOAc–hexane, 1:14 to 1:1) to give the crude acetamide (472 mg).
The acetamide was dissolved in THF (6.0 mL). LiAlH4 (77.0 mg,
2.03 mmol) was stirred to this soln at 0 °C. The mixture was stirred
at r.t. for 1 h; Na2SO4·10 H2O was gradually added to the mixture.
The whole mixture was stirred at r.t. for 6 h, filtered to remove the
white precipitates, and concentrated. The residue was purified by
column chromatography (NH silica gel purchased by Fuji Silysia
Chemical Ltd., hexane–EtOAc, 3:1) to give 9 (192 mg, 70%, 2
steps); 81% ee [HPLC (Daicel Chiralcel OD-H, hexane–i-PrOH,
10:1, 1.0 mL/min)].
(5) (a) Takahashi, G.; Shirakawa, E.; Tsuchimoto, T.;
Kawakami, Y. Chem. Commun. 2005, 1459. (b) For recent
contributions of Ni-catalyzed addition to aldehydes, see: Ni-
catalyzed alkylation of aldehydes with trialkylborane: Hirao,
K.; Yorimitsu, H.; Oshima, K. Org. Lett. 2005, 7, 4689.
(c) Mahandru, G. M.; Liu, G.; Montgomery, J. J. Am. Chem.
Soc. 2004, 126, 3698. (d) Miller, K. M.; Huang, W.-S.;
Jamison, T. F. J. Am. Chem. Soc. 2003, 125, 3442.
(6) For our preliminary communication see: Arao, T.; Kondo,
K.; Aoyama, T. Tetrahedron Lett. 2007, 48, 4115.
(7) For a recent review, see: Darses, S.; Genet, J. P. Chem. Rev.
2008, 108, 288.
(8) h2-Coordinated nickel complexes with aldehydes have been
reported: (a) Ogoshi, S.; Oka, M.; Kurosawa, H. J. Am.
Chem. Soc. 2004, 126, 11802. (b) Ogoshi, S.; Kamada, H.;
Kurosawa, H. Tetrahedron 2006, 62, 7583.
[a]D27 +11 (c 3.61, THF).
IR (neat): 1117, 1095, 1074 cm–1.
(9) (a) Tomita, D.; Wada, R.; Kanai, M.; Shibasaki, M. J. Am.
Chem. Soc. 2005, 127, 4138. (b) Tomita, D.; Kanai, M.;
Shibasaki, M. Chem. Asian J. 2006, 1-2, 161.
(10) Bolm, C.; Rudolph, J. J. Am. Chem. Soc. 2002, 124, 14850.
(11) For new tuned Duphos derivatives, see: Oisaki, K.; Zhao, D.;
Suto, Y.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2005,
46, 4325.
(12) Ohkuma, T.; Koizumi, M.; Ikehira, H.; Yokozawa, T.;
Noyori, R. Org. Lett. 2000, 2, 659.
(13) Wu, X.; Liu, X. X.; Zhao, G. Tetrahedron: Asymmetry 2005,
16, 2299.
1H NMR (CDCl3): d = 2.25 (s, 9 H), 2.58 (t, J = 6.1 Hz, 2 H), 3.56
(br t, J = 5.9 Hz, 2 H), 5.53 (s, 1 H), 7.09–7.44 (m, 9 H).
13C NMR (CDCl3): d = 19.47, 46.01, 59.03, 67.54, 81.27, 125.79,
126.95, 127.16, 127.21, 127.41, 128.05, 130.32, 135.69, 139.64,
140.99.
MS (FAB): m/z = 270 (M+ + 1).
Anal. Calcd for C18H23NO: C, 80.26; H, 8.61; N, 5.20. Found: C,
79.84; H, 8.77; N, 5.00.
(14) Sharshira, E. M.; Okamura, M.; Hasegawa, E.; Horaguchi,
T. J. Heterocycl. Chem. 1997, 34, 861.
Synthesis 2008, No. 22, 3585–3590 © Thieme Stuttgart · New York